| Announce Date | 01/27/2026 |
| EPS Normalized Actual | $3.11 (Beat by $0.33) |
| EPS GAAP Actual | $3.11 (Beat by $0.33) |
| Revenue Actual | $2.825B |
| Revenue Surprise | Beat by $2825M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 21.5433 | 19.93 | 19.56504 | 23.13726 | 1 |
| Jun 2030 | 21.5433 | 19.93 | 20.04015 | 22.69654 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | 2.73 | 2.73 | 2.825B | 23.54% | 2825M |
| FQ4 2025 (Oct 2025) | 2.58 | 2.58 | 2.629B | 11.56% | 2629M |
| FQ2 2025 (Jun 2025) | 2.3 | 2.3 | 2.444B | 22.79% | 2444M |
| FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 2.16B | 23.38% | 2160M |
| FQ4 2024 (Dec 2024) | -1.45 | -1.45 | 2.325B | 33.12% | 2325M |
| FQ3 2024 (Sep 2024) | 1.45 | 1.45 | 2.168B | 32.93% | 2168M |
| FQ2 2024 (Jun 2024) | 2.44 | 2.44 | 1.887B | 15.1% | 1887M |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 1.655B | -12.39% | 1655M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 4.8696 | -- | 4.62003 | 5.18357 | 5 |
| FQ2 2028 (Apr 2028) | 4.68284 | -- | 4.44284 | 4.98477 | 10 |
| FQ1 2028 (Jan 2028) | 4.92359 | -- | 4.67125 | 5.24104 | 7 |
| FQ4 2027 (Oct 2027) | 5.53132 | -- | 5.24783 | 5.88796 | 4 |
| FQ3 2027 (Jul 2027) | 5.36353 | -- | 5.08864 | 5.70935 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 3.51B | -- | 3.37B | 3.68B | 4 |
| FQ2 2028 (Apr 2028) | 3.51B | -- | 3.37B | 3.69B | 4 |
| FQ1 2028 (Jan 2028) | 3.61B | -- | 3.46B | 3.79B | 4 |
| FQ4 2027 (Oct 2027) | 3.75B | -- | 3.6B | 3.94B | 5 |
| FQ3 2027 (Jul 2027) | 3.67B | -- | 3.52B | 3.85B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | 2.73 | 2.73 | 100% | |
| FQ4 2025 (Oct 2025) | 2.58 | 2.58 | 100% | |
| FQ2 2025 (Jun 2025) | 2.3 | 2.3 | 100% | |
| FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 100% | |
| FQ4 2024 (Dec 2024) | -1.45 | -1.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.45 | 1.45 | 100% | |
| FQ2 2024 (Jun 2024) | 2.44 | 2.44 | 100% | |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | $0B | $2.83B | $2825M | 100% |
| FQ4 2025 (Oct 2025) | $0B | $2.63B | $2629M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.44B | $2444M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.16B | $2160M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.33B | $2325M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.17B | $2168M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.89B | $1887M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.66B | $1655M | 100% |